Particle.news
Corporate Strategy Corporate Transactions Corporate Acquisitions Corporate Takeovers Private Equity Takeover Bids Valuation Takeovers Market Trends Pharmaceuticals
The deal adds privileged access management capabilities to shore up defenses against AI-era threats with a closing expected in the second half of fiscal 2026.
